Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Ann Thorac Surg. 2014 Aug 7;98(5):1755–1761. doi: 10.1016/j.athoracsur.2014.05.070

Table 1.

Patient Characteristics (N=346)

Characteristic Stage IIIA (N=346) Stage I and II (N=1294)
Female 193 (56) 752 (58)
Age, years (mean ± SD) 65 ± 10 69 ± 10
FEV 1, % predicted (mean ± SD) 87 ± 18 89 ± 21
Current or past smoker 308 (89) 1098 (85)
Neoadjuvant therapy
  Yes 195 (56) 0
    Chemotherapy 168 (49)
    Chemoradiation 26 (8)
    Radiation 1 (0.2)
Procedure
  Lobectomy 265 (77) 955 (74)
  Pneumonectomy 46 (13) 17 (1)
  Bilobectomy 19 (5) 22 (2)
  Wedge 10 (3) 188 (15)
  Segmentectomy 5 (1) 111 (9)
Histologic profile
  Adenocarcinoma 227 (66) 995 (77)
  Squamous cell 70 (20) 222 (17)
  Other 25 (7) 45 (3)
  Large cell 18 (5) 32 (2)
  Adenosquamous 5 (1) 0
  Bronchioloalveolar carcinoma 1 (0.2) 0
Adjuvant therapy
  Yes 187 (54) 202 (16)
  Chemotherapy 127 (37) 192 (15)
  Radiation 40 (12) 1 (<1)
  Chemotherapy + radiation 20 (6) 1 (<1)
  Unknown 15 (4) 8 (1)